Italy Biotechnology Market Summary, Competitive Analysis and Forecast to 2028
Summary
Biotechnology in Italy industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
The biotechnology market encompasses a broad range of technologies, products, and services that utilize biological systems, organisms, or derivatives to develop or modify processes or products for specific applications.
The Italian biotechnology market recorded revenues of $16.4 billion in 2023, representing a compound annual growth rate (CAGR) of 3.7% between 2018 and 2023.
The environment & industrial processing segment accounted for the market's largest proportion in 2023, with total revenues of $4.6 billion, equivalent to 28.1% of the market's overall value.
Italian biotech companies have significantly contributed to the fight against COVID-19, focusing on gene sequencing, identifying disease-causing receptors, and developing vaccines, antiviral drugs, and monoclonal antibodies. The red biotech sector accounts for half of these companies, with pharmaceutical and medical device biotech firms generating 74% of turnover.
Scope
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Italy
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Italy
Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Italy biotechnology market with five year forecasts
Reasons to Buy
What was the size of the Italy biotechnology market by value in 2023?
What will be the size of the Italy biotechnology market in 2028?
What factors are affecting the strength of competition in the Italy biotechnology market?
How has the market performed over the last five years?
What are the main segments that make up Italy's biotechnology market?
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do the leading players follow?
7.3. What is the rationale behind recent M&A activity?
8 Company Profiles
8.1. A Menarini Industrie Farmaceutiche Riunite Srl
8.2. Recordati S.p.A.
8.3. Zambon Co SpA
8.4. AGC Biologics SpA
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Italy biotechnology industry value: $ million, 2018-23
Table 2: Italy biotechnology industry category segmentation: % share, by value, 2018-2023
Table 3: Italy biotechnology industry category segmentation: $ million, 2018-2023
Table 4: Italy biotechnology industry geography segmentation: $ million, 2023
Table 5: Italy biotechnology industry value forecast: $ million, 2023-28
Table 6: A Menarini Industrie Farmaceutiche Riunite Srl: key facts
Table 7: A Menarini Industrie Farmaceutiche Riunite Srl: Key Employees